FDA Investigator Traci M Armand

Traci M Armand has inspections in 1 countries as of 26 Oct 2023. Traci M Armand has collaborated with a combinined 3439 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
403
Last Inspection Date:
26 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100006443
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker, Abraham M Maekele, Alec D Fabus, Alexis O Robinson, Amanda B Vega, Amy A Johnson, Amy H Ruble, Andrew J Mcguffin, Andrew Saunders, Angela E Glenn, Ann B Borromeo, Annette Melendez, Armando Chavez, MS, Barbara D Wright, Barbara S Manson, Barbara T Carmichael, Bill Tacket, Jr, Brandon L Mariner, Brandy D Brown, Brant M Schroeder, Brentley S Collins, Brian S Lynch, Brunilda Torres, Carman, Carmen M Chan, Chantae D Mitchell, Charles D Boison, Charles N Dupont, Charles S Watson, Cheryl A Clausen, Cheryl G Scott, Christopher J Adams, Christopher T Smith, Claire M Minden, Clausnitzer, Cody D Rickman, Combs, Courtney A Gilbert, Craig A Garmendia, Cynthia L Medlin, Cynthia R Crocker, Cynthia R Gibson, Dana M Daigle, Dana M Klimavicz, Daniel L Aisen, Danielle M Maddox, Daphne A Videau, Darcy L Webber, David J Leray, David P Vanhouten, David R Heiar, Dawn P Hall, Debra A Taylor, Devaughn Edwards, Diana L Kelsch, Diana M Guidry, Diane Hall, Diane L Kelsch, Diane S Douglas, Dionne D Arline, Donald J Mee, Donna D Gallien, MPH, Dwayne A Miller, Eddie J Rigsby, Edward A Brunt, Edwards, Elizabeth D Connell, Emily E Smith, Erika M Wilkerson, Ernest A Clausnitzer, Ernest L Levins, Esra Toussaint, Fabian Nchaparro Rodriguez, Francis A Guidry, Gary E Coleman, Jr, REHS, Gene R Gunn, German Rivera, Gloria A Milster, Harry R Bringger, Jr, Henry E Sanchez, Herbert M Corbello, Herman S Clincy, Holly M Scott, Hromyak, Hunt, Ivan E Reyes, Ivy Z Bevill, James W Blakely, Jana L Caylor, Janet B Abt, Jason D Abel, Jason P Aun, Jeff, Jerry T Hunt, Jessica A Stephens, Jessica E Hensley, Joan A Loreng, John A Iwen, Jolanna A Norton, Jontae D Sanders, Jose R Hernandez, Joseph B Carballa, Juanelma H Palmer, Julie D Bringger, Karen Gale Sego, Kari L Batey, Kate E Jesse, Kathleen D Culver, Kellie L Thommes, RN, Kelly I Anderson, Kena M Senegal, Kenneth L Smalls, Kenneth R Merritt, Kip J Hanks, Konsuela Y Glass, Lacey J Chessor, Ladislav Kermet, Lakisha N Morton, Lareese K Thomas, Larry A Estavan, Latrice G Jones, Laura E Garcia, Lawrence A Butler, LCDR Randall L Morris, Leena Thomas, Leisha R Shipes, Leo J Lagrotte, Leon L Crawley, Leroy Terrelonge, Linda Agregory Duty, Lindsay H Bertling, Llopis, LT Daveta L Bailey, LT Kimberly M Hull, LT Richard A Lyght, Lundy H Patrick, Lura D Baquero, Madelyn Renteria, Marcus A Green, Margaret E Slimbach, Markeesa M Scales, Marshall H Kinsey, Marvin D Jones, Mary T Carden, Matthew B Thomaston, Megan R Anderson, Melanie G Warzala, Melanie L Drayton, Melanie W Pishnery, Melinda B Lewis, Michelle D Haamid, Mizanne E Lewis, Mpris Inspector, Munoz, Myla D Chapman, Natalie A Guidry, Natasha N Mccants, Nisha C Patel, Oregan, Ormond, Patricia S Smith, Paul L Figarole, Jr, Phuong L Tran, Randy L Clarida, Rebecca A Asente, Richard J Bashay, Richard K Vogel, Ronnie E Jackson, Rosia E Nesbitt, Samantha J Bradley, Samantha J Pinizzotto, D V M, Samuel L Collins, Sandra Carpio, Sandricka M Mosley, Scott A Watson, Shannon Atlas, Sheri L Stephenson, Shusheen A Alexander, Shymetris M Allen, Sidney M Smith, Smith, Sonia M Monges, State Agency, Susanne M Richardson, MSc RAC ELS, Taylor G Barker, Thai D Truong, Thomas O Morgan, Thomas R Stanley, Thomaston, Tiana M Mckinley, Timothy P Lafave, Toni M Booker, Tony E Bable, Traci L Miller, Valerie J Grecek Trinh, Verdell Nelson, Verlinda A Narcisse, Virginia L Meeks, Wanda B Coats, Wayne S Fortenberry, Wendy R Blame, Whitney M White

Traci M Armand's Documents

Publish Date Document Type Title
February, 2005 EIR MDS Pharma Services - EIR, 2005-02-10
November, 2004 FDA 483 Espinoza, Luis MD - Form 483, 2004-11-10
February, 2015 EIR Koren, Michael J., MD - EIR, 2015-02-02
November, 2015 EIR Amit K. Vijapura, M.D. - EIR, 2015-11-23
January, 2005 FDA 483 Response C & M Oxyfill Llc - Form 483R, 2005-01-25
June, 2017 FDA 483 Peter Stacpoole, M.D. - Form 483, 2017-06-15
May, 2004 EIR Christopher Marrero, MD - EIR, 2004-05-27
March, 2005 EIR Hebert, Corey MD - EIR, 2005-03-22
May, 2003 FDA 483 Compass Point Research, Inc. - Form 483, 2003-05-13
April, 2015 FDA 483 Victoria C. Mosteller, M.D. - Form 483, 2015-04-17
May, 2004 FDA 483 Christopher Marrero, MD - Form 483, 2004-05-27
September, 2013 EIR LifeSouth Community Blood Centers, Inc. - EIR, 2013-09-10
April, 2015 FDA 483 Response Victoria C. Mosteller, M.D. - Form 483R, 2015-04-22
April, 2002 EIR Vallette & Associates Inc - EIR, 2002-04-30
August, 2019 EIR Beth E. Safirstein, M.D. - EIR, 2019-08-06
August, 2019 FDA 483 Beth E. Safirstein, M.D. - Form 483, 2019-08-06
August, 2017 FDA 483 Jason E. Lang, M.D. - Form 483, 2017-08-23
August, 2000 EIR Air Liquide America Specialty Gases LLC - EIR, 2000-08-24
March, 2011 FDA 483 Robert Cywes, M.D. - Form 483, 2011-03-09
September, 2019 FDA 483 Gershwin Blyden, M.D. - Form 483, 2019-09-12
April, 2016 FDA 483 Elena Valor, M.D. - Form 483, 2016-04-28
April, 2002 EIR Lertora, MD, Juan JL - EIR, 2002-04-19
February, 2020 FDA 483 Santosh M. Nair, MD - Form 483, 2020-02-26
November, 2016 FDA 483 Charles Klodell, MD - Form 483, 2016-11-03
July, 2013 EIR LifeSouth Community Blood Centers - EIR, 2013-07-30
February, 2005 FDA 483 MDS Pharma Services - Form 483, 2005-02-10
May, 2003 EIR Compass Point Research, Inc. - EIR, 2003-05-13
November, 2004 EIR Espinoza, Luis MD - EIR, 2004-11-10
February, 2016 FDA 483 Joseph, Richard - Form 483, 2016-02-29
January, 2005 FDA 483 C & M Oxyfill Llc - Form 483, 2005-01-20
April, 2015 EIR Victoria C. Mosteller, M.D. - EIR, 2015-04-17
April, 2002 FDA 483 Lertora, MD, Juan JL - Form 483, 2002-04-19
February, 2019 EIR Jorge Lascano, M.D. - EIR, 2019-02-26
November, 2002 FDA 483 Air Liquide Large Industries U.S. LP - Form 483, 2002-11-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more